Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alleghany Corporation is a major investment holding company that was acquired by Berkshire Hathaway in October 2022 for approximately $11.6 billion. While primarily recognized for its property and casualty insurance operations, the company held significant influence in the life sciences sector through its subsidiary IPS-Integrated Project Services (IPS). IPS is a global leader in providing technical consulting, architecture, engineering, and construction management for complex pharmaceutical and biotechnology manufacturing facilities. Shortly before Alleghany's acquisition by Berkshire Hathaway, its capital division divested its interest in IPS to the private equity firm Berkshire Partners. Today, Alleghany operates as a diversified subsidiary of Berkshire Hathaway, managing a wide range of industrial and service-oriented businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alleghany.